Nanolipidgel for enhanced skin deposition and improved antifungal activity

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 222-233

  Wavikar, Preeti ^a   Vavia, Pradeep ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

in vitro antifungal activity; rheological analysis of gel; solid lipid nanoparticles; terbinafine; texture analysis of gel

Indexed keywords

CARBOMER; GLYCEROL STEARATE; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SAFETY; DRUG SOLUBILITY; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; SKIN IRRITATION; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; GELS; LIPIDS; MALE; NANOSTRUCTURES; RATS; RHEOLOGY; SKIN; X-RAY DIFFRACTION;

EID: 84878548022     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9908-y     Document Type: Article

References (35)

1. Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles. Int J Nanomedicine. 2007;2:595-607.
2. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semisolid lipid-based formulations. Adv Drug Deliv Rev. 2008;60:734-6.
3. Alberti I, Kalia YN, Naik A, Bonny J, Guy RH. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm. 2001;219:11-9.
4. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126:2-7.
5. Novartis. Prescribing information for lamisil (terbinafine hydrochloride), antifungal agent. Dorval, 1993; control no. 107515.
6. Amichai BA, Grunwald MH. Adverse drug reactions of the new oral antifungal agents - terbinafine, fluconazole, and itraconazole. Int J Dermatol. 1998;37:410-5.
7. Sachdeva V, Siddoju S, Yu YY, Kim HD, Friden PM, Banga AK. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Int J Pharm. 2010;88:24-31.
8. Wissing SA, Muller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254:65-8.
9. Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine. 2009;5:90-5.
10. Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165-96.
11. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131-55.
12. Muller RH, Mader K, Gohla SH. Solid lipid nanoparticles (SLN) for controlled drug delivery review of the state of the art. Eur J Pharm Biopharm. 2000;50:161-17.
13. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278:71-7.
14. ZurMuhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur J Pharm Biopharm. 1998;45:149-55.
15. Jenning V, Gysler A, Korting MS, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2003;49:211-8.
16. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 2006;110:296-306.
17. Liua J, Hub W, Chena H, Nib Q, Xua H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328:191-5.
18. Wissing SA, Muller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. Eur J Pharm Biopharm. 2003;56:67-72.
19. Lippacher A, Muller RH, Mader K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int J Pharm. 2001;214:9-12.
20. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60:734-46.
21. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N, Patil N. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech. 2009;10:289-96.
22. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm. 2008;363:132-8.
23. Bonacucina G, Cespi M, Palmieri GF. Characterization and stability of emulsion gels based on acrylamide/sodium acryloyldimethyl taurate copolymer. AAPS PharmSciTech. 2009;10:368-75.
24. Chawla V, Saraf SA. Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Colloids Surf B Biointerfaces. 2012;92:293-8.
25. Kennedy RS, Kennedy ML. Effect of non-ionic surfactants on the flow behaviour of aqueous veegum suspensions. AAPS PharmSciTech. 2007;8:E171-6.
26. Park EK, Song PW. Rheological evaluation of petroleum jelly as a base material in ointment and cream formulations: steady shear flow behaviour. Arch Pharm Res. 2010;33:141-50.
27. Chow KT, Chan LW, Heng PW. Formulation of hydrophilic nonaqueous gel: drug stability in different solvents and rheological behaviour of gel matrices. Pharm Res. 2008;25:207-17.
28. Jones DS, Lawlor MS, Woolfson D. Examination of flow rheological and texture properties of polymer gel composed of poly(methyl vinylether-co-maleic anhydride) and poly (vinylpyrrolidone): rheological and mathematical interpretation of textural parameters. J Pharm Sci. 2002;91:2090-101.
29. Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech. 2006;7:E63-9.
30. Viet DQ, Sarawade PB, Hilonga A, Kim J, Chai YG, Kim SH, et al. Preparation of silver nanoparticle containing silica micro beads and investigation of their antibacterial activity. Appl Surf Sci. 2011;257:6963-70.
31. McCarron PA, Donnelly RF, Marouf W, Calvert DE. Anti-adherent and antifungal activities of surfactant-coated poly (ethyl cyanoacrylate) nanoparticles. Pharma Nanotech. 2007;340:182-90.
32. Wang Q, Zhang N, Hu X, Yang J, Du Y. Alginate/polyethylene glycol blend fibers and their properties for drug controlled release. J Biomed Mater Res. 2007;82A:122-8.
33. Wang Q, Hu X, Du Y, Kennedy JF. Alginate/starch blend fibers and their properties for drug controlled release. Carbohydr Polym. 2010;82:842-7.
34. Wang Q, Zhang N, Hu X, Yang J, Du Y. Chitosan/polyethylene glycol blend fibers and their properties for drug controlled release. J Biomed Mater Res A. 2008;85A:881-7.
35. Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Effect of surfactant coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci. 2009;334:75-81.